Information Library
Results for: Consulting - Regulatory & Quality
In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions. Search our library today.
- Sort by:
- Recently Added
- Title
-
Podcast: Addressing Compliance Challenges
Hear from the Experts — April 20, 2012
Bob Rhoades and Marie McDonald, from Consulting at Quintiles, discuss some of the top reasons biopharmaceutical companies fail to make progress on the compliance maturity curve. -
Robust Audit Programs
Hear from the Experts — April 20, 2012
Good internal audit programs and auditing practices enable an organization to evaluate the effectiveness of its Quality Management System, and promote continuous improvement. -
Turkey Oncology Capabilities
Brochure — February 6, 2012
Turkey has outstanding access to patients with a population of almost 75 million. Quintiles recent experience demonstrates Turkey provides rapid patient enrollment with high patient retention rates and remains an emerging market with few competing studies – becoming a major hub for patient recruitment. -
Middle East Oncology capabilities
Brochure — February 6, 2012
Outstanding access to patients in the Middle East region with a population of over 200 million means this is an important emerging region for the biopharmaceutical industry and Quintiles has a proven track record of rapid patient enrollment with high patient retention rates. -
Sustainable Compliance Begins with a Strong Foundation
Brochure — December 8, 2011
The urgency of a problem often entices people to quickly focus on finding a solution and repairing the problem in order to immediately remedy the situation. -
Leveraging Compliance for Sustainable Business Advantage
Hear from the Experts — November 16, 2011
Article from Update Magazine, a publication of FDLI. “Leveraging Compliance for Sustainable Business Advantage” by Robert A. Rhoades, VP, Quality & Compliance Consulting -
Quintiles Addresses Key Considerations for Successful Biosimilar Development
Press Release — September 29, 2011 – Regulatory and commercial considerations are the primary drivers for successful biosimilar development, according to a new report from Quintiles.
-
Quintiles Helps Biopharma Companies Turn Compliance into a Business Advantage
Press Release — June 29, 2011 – Elevating compliance to achieve a strategic advantage allows biopharmaceutical companies to respond more rapidly to ever-changing conditions in the New Health, according to a new report from Consulting at Quintiles.
-
Quintiles Names Rick Sax New Head of Integrated Clinical Services
Press Release — May 23, 2011 – Quintiles announced the appointment of Frederic “Rick” Sax as Senior Vice President and Global Head of its Integrated Clinical Services division.rograms.
-
The Art of Compliance
White Paper — April 21, 2011
The Art of Compliance is more than just meeting regulatory requirements for a new drug, biologic or medical device. It is the ability to elevate compliance beyond execution to achieve strategic advantage. Its insight-based solutions facilitate quick and appropriate response to repidly changing conditions.
